For example, plasma and pleural effusions from NSCLC patients with high levels of the S100A6 protein—a member of the S100 family with pro-apoptotic function—presented longer survival time compared with S100A6-negative cases [118,119]. This evidence concerns the gene S100A6 and non-small cell lung carcinoma.